Bill C-265
An Act to amend the Food and Drugs Act (List of Therapeutic Products Pre-approved for Special Access)
Bill C-265 is at second reading in the House.
Other Bills Numbered C-265
Bill numbers are reused for different bills each new session. This bill number appeared in 14 sessions:
An Act to amend the Food and Drugs Act (List of Therapeutic Products Pre-approved for Special Access)
An Act respecting the development of a national perinatal mental health strategy
Émilie Sansfaçon Act
Secure, Adequate, Acessible and Affordable Housing Act
Canada Post-Secondary Education Act
Canada Post-Secondary Education Act
An Act to amend the Pension Benefits Standards Act, 1985 (protection of assets)
An Act to amend the Pension Benefits Standards Act, 1985 (protection of assets)
An Act to amend the Employment Insurance Act (qualification for and entitlement to benefits)
An Act to amend the Employment Insurance Act (qualification for and entitlement to benefits)
An Act to amend the Income Tax Act (exemption from taxation of 50% of United States social security payments to Canadian residents)
Proportional Representation Review Act
Proportional Representation Review Act
A Day for Hearts: Congenital Heart Defect Awareness Day Act
Division Votes (1)
2nd reading of Bill C-265, An Act to amend the Employment Insurance Act (illness, injury or quarantine)
Vote by party
Parliamentary Debates (49)
Speeches in the House of Commons that mention Bill C-265.
Private Members' Business
Mr. Speaker, I am grateful for the chance to finish my remarks about Bill C-265, an act to amend the Food and Drugs Act regarding a list of therapeutic products pre-approved for special access. In the interregnum between the first and second half of my remarks, members of my com…
Read full speech →Private Members' Business
Mr. Speaker, I am pleased to rise today to speak to Bill C-265. I want to first thank my good friend, the member for Thunder Bay—Rainy River, for bringing forward this important bill and legislation. As many members know, he brings a unique perspective to the Ho…
Read full speech →Private Members' Business
… after patients in the United States and Europe have access to them. This is the broken system that Bill C-265 is trying to address. The bill would direct the Minister of Health to establish a standing pre-approved list of non-marketed therapeutic products for serious or life-threatening conditions. Physician…
Read full speech →Private Members' Business
The House resumed from May 8 consideration of the motion that Bill C-265, An Act to amend the Food and Drugs Act (List of Therapeutic Products Pre-approved for Special Access), be read the second time and referred to a committee.
Read full speech →Private Members' Business
…pathway is hindered by layers of administration that fail to deliver the outcome that was intended. Bill C-265 intends to address this problem with a straightforward proposal. It would direct the Minister of Health to establish a standing, pre-approved list of non-marketed therapeutic products for serious or …
Read full speech →Private Members' Business
…cess life-saving drugs are too much paperwork and too much bureaucracy. That is why we are debating Bill C-265 today, so we can get life-saving drugs to Canadians who need them in a timely and efficient manner. This is an act to amend the Food and Drugs Act. To be more clear, it is meant to provide a list of …
Read full speech →Private Members' Business
Mr. Speaker, I rise today in support of Bill C-265, introduced by my colleague, the member for Thunder Bay—Rainy River. I want to thank him for bringing forward this important legislation and for his advocacy on behalf of patients and families across…
Read full speech →Private Members' Business
Mr. Speaker, it is a pleasure to speak today on Bill C-265. It is worth emphasizing that the intention behind this bill is a very noble one. Facilitating access to therapeutic products for patients seeking access to innovative drugs or therapies when that is…
Read full speech →Private Members' Business
…that my colleague for Thunder Bay—Rainy River is trying to solve through his private member's bill, Bill C-265. I am proud to rise today in strong support of this bill, brought forward by my friend and colleague, who is an ER physician and a member of this House. He understands, better than most of us, what i…
Read full speech →Private Members' Business
…t when certain criteria are met. Basically, it is similar to the pre-approved drug list in my bill, Bill C-265. They found that the program significantly reduced time-to-drug initiation from the time of request. In the case of one antibiotic, it was a little over seven days, and in the case of another, it was…
Read full speech →